Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Transplantation. 2015 Feb;99(2):360–366. doi: 10.1097/TP.0000000000000588

Figure 2. Expected patient survival after the choice between primary living donor versus deceased donor KT: illustrative patient and donor phenotypes.

Figure 2

Figure 2

Figure 2

Figure 2

2A: Living donor is a 20 year-old Caucasian female, HLA mismatches = 0, no smoking history

2B: Living donor is a 50 year-old Caucasian male, HLA mismatches = 6, smoking history

2C: Candidate is a 10 year-old Caucasian male, CAKUT, PRA 0–5%, ABO O, no prior dialysis or KT

2D: Candidate is a 15 year-old African American female, FSGS, PRA 96–100%, ABO B, no prior dialysis, previous KT

Candidate for Figure 2A–B: 5 year-old Caucasian male, CAKUT, PRA 0–5%, ABO O, no prior dialysis or KT, expected pediatric time to deceased donor KT = 6 months, expected adult time to deceased donor KT = 2 years. Living donor for Figure 2C–D: 30 year-old Caucasian male, HLA mismatches = 3, no smoking history, expected pediatric time to deceased donor KT = 6 months, expected adult time to deceased donor KT = 2 years.